Evaluation of Biliary Reflux After Mini-gastric Bypass With Using the Biliary Reflux Index
Launched by PRIVATE HEALTHCARE INSTITUTION CLINICAL HOSPITAL RGD-MEDICINE · Apr 10, 2021
Trial Information
Current as of April 26, 2025
Unknown status
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • morbid obesity
- • BMI above 35 kg/m2 with obesity related comorbidity
- • BMI above 40 kg/m2
- • undergoing MGB/OAGB
- • no bile reflux during preoperative period
- Exclusion Criteria:
- • revisional operations
- • therapy-resistant bile reflux during preoperative period
- • history of bariatric surgery
About Private Healthcare Institution Clinical Hospital Rgd Medicine
Clinical Hospital RGD-Medicine is a leading private healthcare institution dedicated to advancing medical research and improving patient outcomes through innovative clinical trials. With a commitment to excellence in patient care, RGD-Medicine combines state-of-the-art facilities with a team of experienced healthcare professionals to conduct rigorous clinical studies across various therapeutic areas. The institution focuses on fostering collaboration between researchers, healthcare providers, and patients to ensure the highest standards of ethical practice and scientific integrity in all its clinical trial initiatives.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Rostov On Don, , Russian Federation
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials